rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

John Micek

Director

Company insider

Files Form 4 as: Director, Jaguar Health; Director, Innovaro; Chief Financial Officer, Enova Systems; Director, Wherify Wireless.

Every Form 4 they filed

In numbers

Trades disclosed
51
Buys
0
Sells
2
Bought
$0
Sold
$100K
Companies
4
Companies where not an officer
3
First trade
21 Sep 2005
Last trade
11 Dec 2025
Last filed
12 Mar 2026

Companies traded

Where they are an officer
Enova SystemsDirector, Officer · last 19 Dec 20110 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
JAGX Jaguar HealthDirector · Biotechnology · last 11 Dec 20250 buys · 0 sells
InnovaroDirector · last 19 Nov 20120 buys · 2 sells
Wherify WirelessDirector · last 29 Dec 20050 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
11 Dec 2025filed 12 Mar 2026JAGX Jaguar HealthBiotechnologySEC FORM 4 Code A—7,377 at $0.00filing
11 Dec 2025filed 12 Mar 2026JAGX Jaguar Healthoption or derivative · BiotechnologySEC FORM 4 Code A—7,377 at $0.00filing
11 Dec 2025filed 12 Mar 2026JAGX Jaguar Healthoption or derivative · BiotechnologySEC FORM 4 Code A—7,377 at $0.00filing
11 Dec 2025filed 12 Mar 2026JAGX Jaguar HealthBiotechnologySEC FORM 4 Code A—7,377 at $0.00filing
24 Jun 2025filed 26 Jun 2025JAGX Jaguar Healthoption or derivative · BiotechnologySEC FORM 4 Code D$450.0M9,000 at $50,000.00filing
24 Jun 2025filed 26 Jun 2025JAGX Jaguar Healthoption or derivative · BiotechnologySEC FORM 4 Code A$473.1M9,462 at $50,000.00filing
24 Jun 2025filed 26 Jun 2025JAGX Jaguar Healthoption or derivative · BiotechnologySEC FORM 4 Code A—18,262filing
31 Mar 2025filed 2 Apr 2025JAGX Jaguar Healthoption or derivative · BiotechnologySEC FORM 4 Code P$450.0M9,000 at $50,000.00filing
31 Mar 2025filed 2 Apr 2025JAGX Jaguar Healthoption or derivative · BiotechnologySEC FORM 4 Code P—9,000filing
8 Oct 2024filed 10 Oct 2024JAGX Jaguar Healthoption or derivative · BiotechnologySEC FORM 4 Code A—26,500 at $0.00filing
14 Aug 2023filed 14 Aug 2023JAGX Jaguar HealthBiotechnologySEC FORM 4 Code A—68,568 at $0.00filing
17 May 2023filed 19 May 2023JAGX Jaguar Healthoption or derivative · BiotechnologySEC FORM 4 Code M—1,145 at $0.00filing
17 May 2023filed 19 May 2023JAGX Jaguar HealthBiotechnologySEC FORM 4 Code M—1,145filing
18 May 2022filed 18 May 2022JAGX Jaguar Healthoption or derivative · BiotechnologySEC FORM 4 Code M—12,133 at $0.00filing
18 May 2022filed 18 May 2022JAGX Jaguar HealthBiotechnologySEC FORM 4 Code M—12,133filing
28 Mar 2022filed 30 Mar 2022JAGX Jaguar Healthoption or derivative · BiotechnologySEC FORM 4 Code A—85,900 at $0.00filing
18 May 2021filed 20 May 2021JAGX Jaguar Healthoption or derivative · BiotechnologySEC FORM 4 Code A—72,750 at $0.00filing
18 May 2021filed 20 May 2021JAGX Jaguar Healthoption or derivative · BiotechnologySEC FORM 4 Code A—36,400 at $0.00filing
20 Mar 2020filed 24 Mar 2020JAGX Jaguar Healthoption or derivative · BiotechnologySEC FORM 4 Code A—26,533 at $0.00filing
24 Jul 2019filed 26 Jul 2019JAGX Jaguar Healthoption or derivative · BiotechnologySEC FORM 4 Code A—121,573 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed2

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.